(P-2025) Resistance Analyses from the Remdesivir Phase 2/3 CARAVAN Study in Pediatric and Neonatal Participants Hospitalized with COVID-19

Saturday, October 19, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

JL

Jiani Li, PhD

Gilead Sciences, Inc.
Foster City, California, United States
Lauren Rodriguez, PhD

Research Scientist
Gilead Sciences, Inc.
Foster City, CA, United States
DH

Dong Han, MS

Gilead Sciences, Inc.
Foster City, California, United States
SX

Simin Xu, MS

Gilead Sciences, Inc.
Foster City, California, United States
PH

Pui Yan Ho, PhD

Gilead Sciences, Inc.
Foster City, California, United States
NP

Nadine Peinovich, MPH

Gilead Sciences, Inc.
Foster City, California, United States
CM

Clarissa Martinez, MPH

Gilead Sciences, Inc.
Foster City, California, United States
SC

Silvia Chang, Masters

Associate Scientist
Gilead Sciences
Foster City, California, United States
KK

Kathryn Kersey, MS

Gilead Sciences, Inc.
Foster City, California, United States
JP

Jason K. Perry, PhD

Gilead Sciences, Inc.
Foster City, California, United States
DP

Danielle P. Porter, PhD

Sr. Director
Gilead Sciences Inc
Foster City, California, United States
Charlotte Hedskog, PhD (she/her/hers)

Senior Research Scientist
Gilead Sciences, Inc.
Foster City, California, United States